GAITHERSBURG, M.D., March 12, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs (AIDX), an early market entrant in cutting-edge, AI powered laboratory-based blood tests for the early detection and prevention of ...
Spread the loveIn a groundbreaking study conducted in Sweden, researchers have unveiled how artificial intelligence (AI) can significantly enhance the early detection of melanoma, a serious form of ...
Head and neck cancers represent a biologically heterogeneous group of malignancies requiring accurate diagnosis, staging, and risk stratification for ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
OneTest™ for Cancer is a multi-cancer early detection, or MCED, blood test, and OneTest for Longevity, which measures inflammatory biomarkers, expected to launch in the first half of 2026. OneTest’s ...